-
L.
Mulligan,
C.
Eng,
C.
Healey,
D.
Clayton,
J.
Kwok,
E.
Gardner,
M.
Ponder,
A.
Frilling,
C.
Jackson,
H.
Lehnert,
H.
Neumann,
S.
Thibodeau,
B.
Ponder
(1994)
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC
Nature Genetics, 6
-
C.
Beldjord,
F.
Desclaux-Arramond,
M.
Raffin-Sanson
(1994)
The RET proto-oncogene in sporadic pheochromocytomas
Am _7 Hum Genet Suppl, 55
-
T.
Stelwagen,
R.
Hofstra,
R.
Stulp,
H.
Nijveen,
G.
Romeo,
R.
Landsvater,
C.
Lips,
C.
Buys
(1994)
Mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomas
Cancer Genetics and Cytogenetics, 77
-
R.
Hofstra,
R.
Landsvater,
I.
Ceccherini,
R.
Stulp,
T.
Stelwagen,
Yin
Luo,
B.
Pasini,
J.
Hoppener,
H.
Amstel,
G.
Romeo,
C.
Lips,
C.
Buys
(1994)
A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma
Nature, 367
-
K.
Foster,
A.
Prowse,
A.
Berg,
S.
Fleming,
M.
Hulsbeek,
P.
Crossey,
F.
Richards,
P.
Cairns,
N.
Affara,
M.
Ferguson-Smith,
Charles
Buys,
Eamonn
Maher
(1994)
Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.
Human molecular genetics, 3 12
-
L.
Mulligan,
J.
Kwok,
C.
Healey,
M.
Elsdon,
C.
Eng,
E.
Gardner,
D.
Love,
S.
Mole,
Julie
Moore,
L.
Papi,
M.
Ponder,
H.
Telenius,
A.
Tunnacliffe,
B.
Ponder
(1993)
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
Nature, 363
-
P.A.
Crossey,
K.
Foster,
F.M.
Richards
(1994)
Molecular genetic investigation of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours
Hum Genet, 93
-
S.
Chew,
P.
Lavender,
A.
Jain,
A.
Weber,
R.
Ross,
J.
Wass,
O.
Besser,
A.
Clark
(1995)
Absence of mutations in the MEN2A region of the ret proto‐oncogene in non‐MEN 2A phaeochromocytomas
Clinical Endocrinology, 42
-
J.
Gnarra,
K.
Tory,
Yongkai
Weng,
L.
Schmidt,
M.
Wei,
Hongzhen
Li,
F.
Latif,
Song-Yuan
Liu,
F.
Chen,
F.
Duh,
I.
Lubensky,
D.
Duan,
C.
Florence,
R.
Pozzatti,
M.
Walther,
N.
Bander,
H.
Grossman,
H.
Brauch,
S.
Pomer,
J.
Brooks,
W.
Isaacs,
M.
Lerman,
B.
Zbar,
W.
Linehan
(1994)
Mutations of the VHL tumour suppressor gene in renal carcinoma
Nature Genetics, 7
-
H.
Donis-Keller,
S.
Dou,
D.
Chi,
K.
Carlson,
K.
Toshima,
T.
Lairmore,
J.
Howe,
J.
Moley,
J.
Moley,
P.
Goodfellow,
S.
Wells
(1993)
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
Human molecular genetics, 2 7
-
D.
Gutmann,
R.
Geist,
Kamala
Rose,
G.
Wallin,
J.
Moley
(1994)
Loss of neurofibromatosis type I (NFI) gene expression in pheochromocytomas from patients without NFI
Genes, 13
-
S.
Dou,
D.
Chi,
K.M.
Carlson,
J.A.
Moley,
Jr
SA,
H.
Donis-Keller
(1994)
RETproto-oncogene mutations associated with sporadic cases of medullary thyroid carcinoma
-
K.
Carlson,
S.
Dou,
D.
Chi,
N.
Scavarda,
K.
Toshima,
C.
Jackson,
S.
Wells,
P.
Goodfellow,
H.
Donis-Keller
(1994)
Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.
Proceedings of the National Academy of Sciences of the United States of America, 91
-
H.
Neumann
(1987)
Basic criteria for clinical diagnosis and genetic counselling in von Hippel-Lindau syndrome.
VASA. Zeitschrift fur Gefasskrankheiten, 16 3
-
C.
Eng,
Darrin
Smith,
L.
Mulligan,
C.
Healey,
M.
Zvelebil,
T.
Stonehouse,
M.
Ponder,
C.
Jackson,
M.
Waterfield,
B.
Ponder
(1995)
A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.
Oncogene, 10 3
-
C.
Eng,
Darrin
Smith,
L.
Mulligan,
Maria
Nagal,
C.
Healey,
M.
Ponder,
E.
Gardner,
G.
Scheumann,
C.
Jackson,
Alan
Tunnacllffe,
B.
Ponder
(1994)
Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.
Human molecular genetics, 3 2
-
P.
Komminoth,
E.
Kunz,
O.
Hiort,
S.
Schröder,
X.
Matías-Guiu,
G.
Christiansen,
J.
Roth,
P.
Heitz
(1994)
Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing.
The American journal of pathology, 145 4
-
C.
Eng,
L.
Mulligan,
Darrin
Smith,
C.
Healey,
A.
Frilling,
F.
Raue,
H.
Neumann,
R.
Pfragner,
A.
Behmel,
M.
Lorenzo,
T.
Stonehouse,
M.
Ponder,
B.
Ponder
(1995)
Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma
Genes, 12
-
N.
Atuk,
T.
McDonald,
T.
Wood,
J.
Carpenter,
M.
Walzak,
M.
Donaldson,
J.
Gillenwater
(1979)
Familial pheochromocytoma, hypercalcemia, and von Hippel-Lindau disease. A ten year study of a large family.
Medicine, 58 3
-
Paul
A.Crossey,
Frances
M.Richards,
K.
Foster,
Jane
reen,
A.
Prowse,
Farida
Latlf,
M.
Lerman,
B.
Zbar,
Nabeel
Atfara,
M.
Ferguson-Smith,
E.
Maher
(1994)
Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype.
Human molecular genetics, 3 8
-
A.
Bolino,
I.
Schuffenecker,
Yin
Luo,
M.
Seri,
M.
Silengo,
T.
Tocco,
G.
Chabrier,
C.
Houdent,
A.
Murat,
M.
Schlumberger,
J.
Tourniaire,
G.
Lenoir,
Giovanni
Romeo
(1995)
RET mutations in exons 13 and 14 of FMTC patients.
Oncogene, 10 12
-
E.
Maher,
J.
Yates,
R.
Harries,
C.
Benjamin,
R.
Harris,
A.
Moore,
M.
Ferguson-Smith
(1990)
Clinical features and natural history of von Hippel-Lindau disease.
The Quarterly journal of medicine, 77 283
-
R.
Schimke
(1990)
Multiple endocrine neoplasia: how many syndromes?
American journal of medical genetics, 37 3
-
B.
Wieringa
(1994)
COMMENTARY: Myotonic dystrophy reviewed: back to the future?
Human Molecular Genetics, 3
-
L.M.
Mulligan,
D.J.
Marsh,
B.G.
Robinson
Genotypephenotype correlation in MEN 2: report of the International RET Mutation Consortium
-
A.
Feinberg
(1994)
A developmental context for multiple genetic alterations in Wilms’ tumor
Journal of Cell Science, 1994
-
H.
Neumann,
D.
Berger,
Gunther
Sigmund,
U.
Blum,
Dieter
Schmidt,
R.
Parmer,
Brigitte
Volk,
Günter
Kirste
(1993)
Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
The New England journal of medicine, 329 21
-
K.M.
Carlson,
S.
Dou,
D.
Chi
(1994)
Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine
, 91
-
NaglischJ
WhaleyJM,
Gelbert
L
(1994)
Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma
Am _7 Hum Genet, 55
-
C.
Eng,
B.
Ponder
(1993)
The role of gene mutations in the genesis of familial cancers
The FASEB Journal, 7
-
Jan
Zedenlus,
G.
Wallin,
Berth
Hamberger,
M.
Nordenskjöld,
G.
Weber,
C.
Larsson
(1994)
Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s.
Human molecular genetics, 3 8
-
L.
Mulligan,
E.
Gardner,
Barbara
Smith,
C.
Mathew,
B.
Ponder
(1993)
Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2
Genes, 6
-
H.
Vasen,
A.
Kruseman,
H.
Berkel,
E.
Beukers,
C.
Delprat,
R.
Doorn,
R.
Geerdink,
H.
Haak,
W.
Hackeng,
H.
Koppeschaar
(1987)
Multiple endocrine neoplasia syndrome type 2: the value of screening and central registration. A study of 15 kindreds in The Netherlands.
The American journal of medicine, 83 5
-
Vincent
Riccardi
(1981)
Von Recklinghausen neurofibromatosis.
The New England journal of medicine, 305 27
-
F.
Latif,
K.
Tory,
J.
Gnarra,
M.
Yao,
F.
Duh,
M.
Orcutt,
T.
Stackhouse,
I.
Kuzmin,
W.
Modi,
L.
Geil
(1993)
Identification of the von Hippel-Lindau disease tumor suppressor gene.
Science, 260 5112
-
K.
Takaya,
T.
Yoshimasa,
H.
Arai,
N.
Tamura,
Y.
Miyamoto,
H.
Itoh,
K.
Nakao
(1996)
The RET proto-oncogene in sporadic pheochromocytomas.
Internal medicine, 35 6
-
C.
Mathew,
B.
Smith,
K.
Thorpe,
Z.
Wong,
N.
Royle,
A.
Jeffreys,
B.
Ponder
(1987)
Deletion of genes on chromosome 1 in endocrine neoplasia
Nature, 328
-
L.
Mulligan,
Deborah
Marsh,
B.
Robinson,
I.
Schuffenecker,
Jan
Zedenius,
C.
Lips,
Robert
Gagel,
S.
Takai,
W.
Noll,
M.
Fink,
F.
Raue,
André
Lacroix,
S.
Thibodeau,
A.
Frilling,
B.
Ponder,
Charis
Eng
(1995)
Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium
Journal of Internal Medicine, 238
-
L.
Mulligan,
C.
Eng,
Tanla
Attlé,
S.
Lyonnet,
D.
Marsh,
V.
Hyland,
B.
Robinson,
A.
Frilling,
Christine
Verellen-Dumoulln,
Anne
Safar,
D.
Venter,
Arnold
Munnich,
B.
Ponder
(1994)
Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene.
Human molecular genetics, 3 12
-
Fan
Chen,
T.
Kishida,
M.
Yao,
T.
Hustad,
D.
Glavač,
M.
Dean,
J.
Gnarra,
M.
Orcutt,
F.
Duh,
G.
Glenn,
Jane
Green,
Y.
Hsia,
J.
Lamiell,
Hua
Li,
M.
Wei,
L.
Schmidt,
K.
Tory,
I.
Kuzmin,
T.
Stackhouse,
F.
Latif,
W.
Linehan,
M.
Lerman,
B.
Zbar
(1995)
Germline mutations in the von Hippel–Lindau disease tumor suppressor gene: Correlations with phenotype
Human Mutation, 5
-
Lamiell
Jm,
Salazar
Fg,
Hsia
Ye
(1989)
von Hippel-Lindau disease affecting 43 members of a single kindred.
Medicine, 68
-
N.
Lindor,
R.
Honchel,
S.
Khosla,
S.
Thibodeau
(1995)
Mutations in the RET protooncogene in sporadic pheochromocytomas.
The Journal of clinical endocrinology and metabolism, 80 2
-
Jean
Whaley,
J.
Naglich,
L.
Gelbert,
Y.
Hsia,
J.
Lamiell,
Jane
Green,
D.
Collins,
Hartmut
Neumann,
J.
Laidlaw,
F.
Li
(1994)
Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.
American journal of human genetics, 55 6